Skip to main content
Log in

Impact of diabetes and on-arrival hyperglycemia on short-term outcomes in acute heart failure patients

  • EM - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

The impact of diabetes mellitus (DM) and hyperglycemia on short-term prognosis in patients with acute heart failure (AHF) remains controversial as most data comes from series of hospitalized patients. Our purpose was to analyze outcomes in a nation-wide registry of AHF patients attended in emergency department (ED). ED AHF patients were prospectively enrolled, with the index event and the vulnerable post-discharge phase outcomes recorded. The influence of presenting hyperglycemia (> 180 mg/dL) and DM treatment on prognosis were also investigated. All results were adjusted (a) for baseline characteristics. Of 9192 enrolled AHF patients, 4544 (49,4%) were diabetic, with 24% of diabetics and 25.1% of non-diabetic (p = 0.247) directly discharged from the ED also included. Diabetics had higher rates of comorbidities, but were slightly younger and had lower in-hospital and 30 day all-cause mortality than non-diabetics (a-OR = 0.827, 95% CI = 0.690–0980; and a-HR = 0.850, 95% CI = 0.814–1.071, respectively). Conversely, hyperglycemia on-arrival was associated with increased in-hospital, and 30 day all-cause mortality, in both DM (a-OR = 1.933, 95% CI = 1.378–2.712, and a-HR = 1.590, 95% CI = 1.304–1.938, respectively) and non-DM patients (a-OR = 1.498, 95% CI = 1.175–1.909, and a-HR = 1.719, 95% CI = 1.306–2.264, respectively). However, during the vulnerable phase, diabetics had worse short-term outcomes, with higher rates of ED-revisit and rehospitalization. These worse outcomes seemed to be unrelated to the severity of DM. In patients with AHF attended in ED, diabetes was associated with lower index event case fatality, but higher rates of rehospitalization and re-consultation in the vulnerable post-discharge period. Conversely, hyperglycemia at hospital arrival was strongly associated with early mortality, regardless of diabetes status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27:1879–1884

    Article  PubMed  Google Scholar 

  2. Dei Cas A, Khan SS, Butler J, Mentz RJ, Bonow RO, Avogaro A, Tschoepe D, Doehner W, Greene SJ, Senni M et al (2015) Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail 3:136–145

    Article  PubMed  Google Scholar 

  3. Thomas MC (2016) Type 2 diabetes and heart failure: challenges and solutions. Curr Cardiol Rev 12:249–255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, On behalf of the ESC-HFA HF Long-Term Registry investigators et al (2017) In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA heart failure long-term registry. Eur J Heart Failure 19:54–65

    Article  CAS  Google Scholar 

  5. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN et al (2014) The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 63:1123–1133

    Article  PubMed  Google Scholar 

  6. Echouffo-Tcheugui JB, Xu H, DeVore AD, Schulte PJ, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Heidenreich PA, Fonarow GC (2016) Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from get with the guidelines-heart failure registry. Am Heart J 182:9–20

    Article  PubMed  Google Scholar 

  7. Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 24:1614–1619

    Article  CAS  PubMed  Google Scholar 

  8. Gilbert RE, Krum H (2015) Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet 385:2107–2117

    Article  CAS  PubMed  Google Scholar 

  9. Kodama S, Fujihara K, Horikawa C, Sato T, Iwanaga M, Yamada T, Kato K, Watanabe K, Shimano H, Izumi T et al (2020) Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis. ESC Heart Fail 7:2146–2174

    Article  PubMed  PubMed Central  Google Scholar 

  10. Seferović PM, Petrie MC, Filippatos GS, Anker SD, Rosano G, Bauersachs J, Paulus WJ, Komajda M, Cosentino F, de Boer RA et al (2018) Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 20:853–872

    Article  PubMed  Google Scholar 

  11. Dauriz M, Targher G, Laroche C, Temporelli PL, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro M, Mebazaa A et al (2017) ESC-HFA heart failure long-term registry. Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA heart failure long-term registry. Diabetes Care 40:671–678

    Article  CAS  PubMed  Google Scholar 

  12. Kristensen SL, Mogensen UM, Jhund PS, Petrie MC, Preiss D, Win S, Kober L, McKelvie R, Zile MR, Anand IS et al (2017) Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction: a report from the I-Preserve trial (Irbesartan in heart failure with preserved ejection fraction). Circulation 135:724–735

    Article  PubMed  Google Scholar 

  13. Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, GISSI-HF Investigators et al (2017) Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. J Am Heart Assoc 6:e005156

    Article  PubMed  PubMed Central  Google Scholar 

  14. Castagno D, Baird-Gunning J, Jhund PS, Biondi-Zoccai G, MacDonald MR, Petrie MC, Gaita F, McMurray JJ, Castagno D, Baird-Gunning J et al (2011) Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. Am Heart J 162:938–948

    Article  CAS  PubMed  Google Scholar 

  15. MacDonald MR, Jhund PS, Petrie MC, Lewsey JD, Hawkins NM, Bhagra S, Munoz N, Varyani F, Redpath A, Chalmers J et al (2008) Discordant short and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 51 million people in Scotland. Circ Heart Fail 1:234–241

    Article  PubMed  Google Scholar 

  16. Sarma S, Mentz RJ, Kwasny MJ, Fought AJ, Huffman M, Subacius H, Nodari S, Konstam M, Swedberg K, Maggioni AP, EVEREST investigators et al (2013) Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Fail 15:194–202

    Article  CAS  PubMed  Google Scholar 

  17. Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Køber L, Torp-Pedersen C, Danish Investigations of Arrhythmia and Mortality on Dofetilde Study Group (2004) Influence of diabetes and diabetes–gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43:771–777

    Article  PubMed  Google Scholar 

  18. Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, Peacock F, Spinar J, Harjola VP, van Kimmenade R, GREAT Network et al (2013) Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol 61:820–829

    Article  CAS  PubMed  Google Scholar 

  19. Targher G, Dauriz M, Tavazzi L, Temporelli PL, Lucci D, Urso R, Lecchi G, Bellanti G, Merlo M, Rossi A, IN-HF Outcome Investigators et al (2016) Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: results of the IN-HF (Italian Network on Heart Failure) outcome registry. Int J Cardiol 203:587–593

    Article  PubMed  Google Scholar 

  20. Kosiborod M, Inzucchi SE, Spertus JA, Wang Y, Masoudi FA, Havranek EP, Krumholz HM et al (2009) Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation 119:1899–1907

    Article  CAS  PubMed  Google Scholar 

  21. Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O’Connor CM, Sun JL, Yancy CW et al (2007) Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). Am Heart J 154(277):e1–e8

    Google Scholar 

  22. Kapoor JR, Fonarow GC, Zhao X, Kapoor R, Hernandez AF, Heidenreich PA et al (2011) Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure. Am Heart J 162:480-486.e3

    Article  PubMed  Google Scholar 

  23. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, Shotan A, Behar S, Caspi A, Schwartz R et al (2006) Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 166:1613–1619

    Article  PubMed  Google Scholar 

  24. Sud M, Wang X, Austin PC, Lipscombe LL, Newton GE, Tu JV, Vasan RS, Lee DS (2015) Presentation blood glucose and death, hospitalization, and future diabetes risk in patients with acute heart failure syndromes. Eur Heart J 36:924–931

    Article  PubMed  PubMed Central  Google Scholar 

  25. Llorens P, Javaloyes P, Martín-Sánchez FJ, Jacob J, Herrero-Puente P, Gil V et al (2018) Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure. Clin Res Cardiol 107:897–913

    Article  PubMed  Google Scholar 

  26. Benito Lozano M, Miró O, Llorens P, Travería L, Pavón Monzó JM, De La Torre AN et al (2021) Acute heart failure in subtropical climates: clinical characteristics, management, and outcomes in the Canary Islands versus continental Spain—the CANAR-ICA study results. Emergencias 33:413–20

    PubMed  Google Scholar 

  27. Llauger L, Jacob J, Arturo Moreno L, Aguirre A, Martín-Mojarro E, Romero-Carrete JC, Martínez-Nadal G, Tost J, Corominas-Lasalle G, Roset À, Cardozo C et al (2020) Worsening renal function during an episode of acute heart failure and its relation to short- and long-term mortality: associated factors in the epidemiology of acute heart failure in emergency departments—worsening renal function study. Emergencias 32:332–339

    PubMed  Google Scholar 

  28. Miró Ò, Rossello X, Gil V, Martín-Sánchez FJ, Llorens P, Herrero-Puente P, Jacob J, Bueno H, Pocock SJ, ICA-SEMES Research Group. ICA-SEMES Research Group (2017) Predicting 30-day mortality for patients with acute heart failure in the emergency department: a cohort study. Ann Intern Med 167:698–705

    Article  PubMed  Google Scholar 

  29. Ho KKL, Anderson KM, Kannel WB, Grosssman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115

    Article  CAS  PubMed  Google Scholar 

  30. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail 18:891–975

    Article  PubMed  Google Scholar 

  31. Álvarez-Rodríguez E, Agud Fernández M, Caurel Sastre Z, Gallego Mínguez I, Carballo Cardona C, Juan Arribas A, Piñero Panadero R, Rubio Casas O, Sáenz Abad D, Cuervo PR (2016) Recommendations for the management of emergencies in patients with diabetes, acute metabolic complications of diabetes, and steroid-related hyperglycemia. Emergencias 28:400–417

    PubMed  Google Scholar 

  32. Diercks DB, Fonarow GC, Kirk JD, Emerman CL, Hollander JE, Weber JE, Summers RL, Wynne J, Peacock WF 4th, ADHERE Scientific Advisory Committee and Investigators (2008) Risk stratification in women enrolled in the acute decompensated heart failure national registry emergency module (ADHERE-EM). Acad Emerg Med 15:151–158

    Article  PubMed  Google Scholar 

  33. Lee DS, Stitt A, Austin PC, Stukel TA, Schull MJ, Chong A, Newton GE, Lee JS, Tu JV (2012) Prediction of heart failure mortality in emergent care. A cohort study. Ann Intern Med 156:767–775

    Article  PubMed  Google Scholar 

  34. Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, PARADIGM-HF Investigators and Committees et al (2016) Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial. Circ Heart Fail 9:e002560

    Article  PubMed  PubMed Central  Google Scholar 

  35. Ukena C, Dobre D, Mahfoud F, Kindermann I, Lamiral Z, Tala S, Rossignol P, Turgonyi E, Pitt B, Bohm M et al (2012) Hypo-and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS. J Card Fail 18:439–445

    Article  CAS  PubMed  Google Scholar 

  36. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, CHARM Investigators et al (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29:1377–1385

    Article  PubMed  Google Scholar 

  37. Sasso FC, Rinaldi L, Lascar N, Marrone A, Pafundi PC, Adinolfi LE, Marfella R (2018) Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes. J Diabetes Res. https://doi.org/10.1155/2018/3106056

    Article  PubMed  PubMed Central  Google Scholar 

  38. Caturano A, Galiero R, Pafundi PC, Cesaro A, Vetrano E, Palmiero G, Rinaldi L, Salvatore T, Marfella R, Sardu C, Moscarella E, Gragnano F, Calabrò P, Sasso FC (2021) Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence. Diabetes Res Clin Pract 178:108959. https://doi.org/10.1016/j.diabres.2021.108959

    Article  CAS  PubMed  Google Scholar 

  39. Marcucci M, Franchi C, Nobili A, Mannucci PM, Ardoino I, REPOSI Investigators (2017) Defining aging phenotypes and related outcomes: clues to recognize frailty in hospitalized older patients. J Gerontol A Biol Sci Med Sci 72:395–402

    PubMed  Google Scholar 

  40. Aguilar GS (2020) Prognosis in heart failure: importance of physical frailty at the time of admission. Emergencias 32:147–148

    Google Scholar 

  41. Martín-Sánchez FJ, Parra Esquivel P, Llopis García G, González Del Castillo J, Rodríguez Adrada E, Espinosa B et al (2021) Thirty-day outcomes in frail older patients discharged home from the emergency department with acute heart failure: effects of high-risk criteria identified by the DEED FRAIL-AHF trial. Emergencias 33:165–173

    PubMed  Google Scholar 

  42. García-Álvarez A (2021) Safety and the identification of modifiable factors in older patients discharged from the emergency department with acute heart failure. Emergencias 33:161–162

    PubMed  Google Scholar 

  43. Sasso FC, Pafundi PC, Simeon V, De Nicola L, Chiodini P, Galiero R, Rinaldi L, Nevola R, Salvatore T, Sardu C, Marfella R, Adinolfi LE, Minutolo R, NID-2 Study Group Investigators (2021) Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease. Cardiovasc Diabetol 20:145

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was possible in part thanks to financial support from the Instituto de Salud Carlos III with funds from the Ministerio de Sanidad and FEDER (PI18/00393, PI18/00773), La Marató de TV3 (2015/2510) and the Generalitat de Cataluna for consolidated research groups (GRC 2009/1385, 2014/0313, 2017/1424). The EAHFE Research group have previously received unconditioned funding from Novartis, Otsuka and Orion Pharma. We thank Alícia Díaz for her professionalism in data management. Investigators of the ICA-SEMES/EAHFE Registry group (full list): Marta Fuentes, Cristina Gil: Hospital Universitario de Salamanca, Héctor Alonso, Enrique Pérez-Llantada: Hospital Marqués de Valdecilla de Santander, Francisco Javier Martín-Sánchez, Guillermo Llopis García, Mar Suárez Cadenas: Hospital Clínico San Carlos de Madrid, Òscar Miró, Víctor Gil, Rosa Escoda, Sira Aguiló, Carolina Sánchez: Hospital Clínic de Barcelona, Javier Millán: Hospital Politénic La Fe de Valencia, José Pavón: Hospital Dr. Negrín de Las Palmas de Gran Canaria, Antonio Noval: Hospital Insular de Las Palmas de Gran Canaria, María Luisa López-Grima, Amparo Valero, María Ángeles Juan: Hospital Dr. Peset de Valencia, Alfons Aguirre, Maria Angels Pedragosa, Silvia Mínguez Masó: Hospital del Mar de Barcelona, María Isabel Alonso, Francisco Ruiz: Hospital de Valme de Sevilla, José Miguel Franco: Hospital Miguel Servet de Zaragoza, Ana Belén Mecina: Hospital de Alcorcón de Madrid, Josep Tost, Marta Berenguer, Ruxandra Donea: Consorci Sanitari de Terrassa, Susana Sánchez Ramón, Virginia Carbajosa Rodríguez: Hospital Universitario Rio Hortega de Valladolid, Pascual Piñera, José Andrés Sánchez Nicolás: Hospital Reina Sofía de Murcia, Raquel Torres Garate: Hospital Severo Ochoa de Madrid, Aitor Alquézar-Arbé, Miguel Alberto Rizzi, Sergio Herrera: Hospital de la Santa Creu y Sant Pau de Barcelona, Javier Jacob, Alex Roset, Irene Cabello, Antonio Haro: Hospital Universitari de Bellvitge de Barcelona, Fernando Richard, José María Álvarez Pérez, María Pilar López Diez: Hospital Universitario de Burgos, Pablo Herrero Puente, Joaquín Vázquez Álvarez, Belén Prieto García, María García Díez, Marta Sánchez González: Hospital Universitario Central de Asturias de Oviedo, Pere Llorens, Patricia Javaloyes, Inmaculada Jiménez, Néstor Hernández, Begoña Espinosa, Adriana Gil, Francisca Molina, Tamara García: Hospital General de Alicante, Juan Antonio Andueza: Hospital General Universitario Gregorio Marañón de Madrid, Rodolfo Romero: Hospital Universitario de Getafe de Madrid, Martín Ruíz, Roberto Calvache: Hospital de Henares de Madrid, María Teresa Lorca Serralta, Luis Ernesto Calderón Jave: Hospital del Tajo de Madrid, Beatriz Amores Arriaga, Beatriz Sierra Bergua: Hospital Clínico Lozano Blesa de Zaragoza, Enrique Martín Mojarro, Brigitte Silvana Alarcón Jiménez: Hospital Sant Pau i Santa Tecla de Tarragona, Lisette Travería Bécquer, Guillermo Burillo: Hospital Universitario de Canarias de Tenerife, Lluís Llauger García, Gerard Corominas LaSalle: Hospital Universitari de Vic de Barcelona, Carmen Agüera Urbano, Ana Belén García Soto, Elisa Delgado Padial: Hospital Costa del Sol de Marbella de Málaga, Ester Soy Ferrer, María Adroher Múñoz: Hospital Josep Trueta de Girona. José Manuel Garrido: Hospital Virgen Macarena de Sevilla, Francisco Javier Lucas-Imbernón: Hospital General Universitario de Albacete, Rut Gaya: Hospital Juan XXIII de Tarragona, Carlos Bibiano, María Mir, Beatriz Rodríguez: Hospital Infanta Leonor de Madrid, José Luis Carballo: Complejo Hospitalario Universitario de Ourense, Esther Rodríguez-Adrada, Belén Rodríguez Miranda, Monika Vicente Martín: Hospital Rey Juan Carlos de Móstoles de Madrid. Pere Coma Casanova, Joan Espinach Alvarós: Hospital San Joan de Deu de Martorell, Barcelona.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

The study is original and has not been submitted elsewhere. None of the paper’s contents have been previously published. All the authors have participated in the design of the study and have reviewed, approved the content of the article and agreed to be accountable for all aspects of the work. The majority have also contributed introducing patients and/or coordinating their inclusion.

Corresponding author

Correspondence to Josep Masip.

Ethics declarations

Conflict of interest

All the authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Ethical approval

The EAHFE Registry protocol was approved by a central Ethics Committee at the Hospital Universitario Central de Asturias (Oviedo, Spain) with the reference numbers for phases 5 and 6 being 160/15 and 205/17. Due to the non-interventional design of the registry, Spanish legislation allows central Ethical Committee approval, accompanied by notification to the local Ethical Committees. All participating patients gave informed consent to be included and to be contacted for follow up. The present study was carried out in strict compliance with the Declaration of Helsinki principles.

Informed consent

All participants gave their informed consent prior the participation. It is specified that this consent was for their inclusion to the study and to be contacted later in the follow-up.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masip, J., Povar-Echeverría, M., Peacock, W.F. et al. Impact of diabetes and on-arrival hyperglycemia on short-term outcomes in acute heart failure patients. Intern Emerg Med 17, 1503–1516 (2022). https://doi.org/10.1007/s11739-022-02965-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-022-02965-3

Keywords

Navigation